Population pharmacokinetics of tofacitinib in patients with active ankylosing spondylitis
Int. Journal of Clinical Pharmacology and Therapeutics · 01.02.2026 · 64 (02) · 57-65
DOI: 10.5414/cp204781 ↗Kurz gefasst
Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.02.2026. Verfasst von Shinichi Tsuchiwata und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Pyrimidines, Piperidines, Spondylitis, Ankylosing, Protein Kinase Inhibitors. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Tsuchiwata, S., Suzuki, A., Wang, Q., Kanik, K., Fallon, L., & Menon, S. (2026). Population pharmacokinetics of tofacitinib in patients with active ankylosing spondylitis. Int. Journal of Clinical Pharmacology and Therapeutics, 64(02), 57-65. https://doi.org/10.5414/cp204781
Vancouver
Tsuchiwata S, Suzuki A, Wang Q, Kanik K, Fallon L, Menon S. Population pharmacokinetics of tofacitinib in patients with active ankylosing spondylitis. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(02):57-65. doi:10.5414/cp204781
BibTeX
@article{Tsuchiwata2026,
author = {Tsuchiwata, Shinichi and Suzuki, Akiyuki and Wang, Qiang and Kanik, Keith and Fallon, Lara and Menon, Sujatha},
title = {Population pharmacokinetics of tofacitinib in patients with active ankylosing spondylitis},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
volume = {64},
number = {02},
pages = {57--65},
doi = {10.5414/cp204781}
}
EUVIMED